A Closer Look at Medicaid Expansion Efforts in Mississippi
This policy watch examines Mississippi's recent Medicaid expansion activity, what expansion could mean for residents and the economy, and key developments to watch.
View the Latest: Coverage
Filter
-
-
Health Care Issues in the Early Stages of the 2024 Election
PerspectiveIn this JAMA Health Forum column, Larry Levitt examines differences in the Republican presidential candidates’ records and positions on health issues, including Medicaid and abortion, that could play a role in the primaries and would set up a sharp contrast in the general election against President Biden.
-
Privately Insured People with Depression and Anxiety Face High Out-of-Pocket Costs
Issue BriefThis analysis finds that privately insured adults who were treated for depression and/or anxiety in 2021 spent almost twice as much on annual out-of-pocket costs compared to enrollees who were not treated for a mental health diagnosis.
-
Climate-Related Health Risks Among Workers: Who is at Increased Risk?
Issue BriefAdults of color, noncitizens, and adults with lower educational attainment and incomes are disproportionately employed in occupations with increased climate-related health risks. Moreover, workers in occupations with increased climate-related health risks are more likely to be uninsured, contributing to challenges accessing health care.
-
KFF Survey of Consumer Experiences with Health Insurance
Poll FindingThe survey finds nearly six in 10 people with health insurance experienced a problem using their insurance in the past year, with even larger shares reporting problems among people who are sick or who have mental health needs. It includes data for people with different types of coverage, including employer, Marketplace, Medicare and Medicaid, and also examines affordability issues and mental health access.
-
What is the Potential Impact of New Drugs for Obesity and Alzheimer’s Disease on Medicare Costs, Coverage and Beneficiaries?
News ReleaseTwo new KFF analyses examine the potential impact of Medicare coverage of new prescription drugs for obesity and Alzheimer’s disease on program spending and beneficiary out-of-pocket costs, as well as the role that the Inflation Reduction Act could play in mitigating these effects.
-
Interest in Using Over-the-Counter Oral Contraceptive Pills: Findings from the 2022 KFF Women’s Health Survey
Issue BriefThis brief presents data from the 2022 KFF Women’s Health Survey about reproductive age (18-49) females’ preferences for an over-the-counter contraceptive pill (N = 4,088).
-
Annual Family Premiums for Employer Coverage Average $22,463 This Year, with Workers Contributing an Average of $6,106, Benchmark KFF Employer Health Benefit Survey Finds
News ReleaseAnnual family premiums for employer-sponsored health insurance average $22,463 this year, similar to last year ($22,221), the 2022 benchmark KFF Employer Health Benefits Survey finds. On average, workers this year are contributing $6,106 toward the cost of family premium, with employers paying the rest.
-
Medicaid’s New Option to Extend Postpartum Coverage for 12 Months Could Prevent Hundreds of Thousands of Enrollees from Losing Coverage in the Months After Delivery
News ReleaseA new KFF analysis finds that hundreds of thousands of people are disenrolled from Medicaid each year after giving birth, which could be prevented if all states were to take up a new option to extend Medicaid postpartum coverage to 12 months.
-
Medicaid: What to Watch in 2023
Issue BriefAs 2023 kicks off, a number of issues are at play that could affect coverage and financing under Medicaid. This issue brief examines key issues to watch in Medicaid in the year ahead.